Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A long-term treatment with taurine prevents cardiac dysfunction in mdx mice.
Mele A, Mantuano P, De Bellis M, Rana F, Sanarica F, Conte E, Morgese MG, Bove M, Rolland JF, Capogrosso RF, Pierno S, Camerino GM, Trabace L, De Luca A. Mele A, et al. Among authors: mantuano p. Transl Res. 2019 Feb;204:82-99. doi: 10.1016/j.trsl.2018.09.004. Epub 2018 Sep 28. Transl Res. 2019. PMID: 30347179
Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase.
Cozzoli A, Liantonio A, Conte E, Cannone M, Massari AM, Giustino A, Scaramuzzi A, Pierno S, Mantuano P, Capogrosso RF, Camerino GM, De Luca A. Cozzoli A, et al. Among authors: mantuano p. Am J Physiol Cell Physiol. 2014 Oct 1;307(7):C634-47. doi: 10.1152/ajpcell.00372.2013. Epub 2014 Jul 30. Am J Physiol Cell Physiol. 2014. PMID: 25080489 Free PMC article.
Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: A comparison with the gold standard, α-methyl prednisolone.
Capogrosso RF, Cozzoli A, Mantuano P, Camerino GM, Massari AM, Sblendorio VT, De Bellis M, Tamma R, Giustino A, Nico B, Montagnani M, De Luca A. Capogrosso RF, et al. Among authors: mantuano p. Pharmacol Res. 2016 Apr;106:101-113. doi: 10.1016/j.phrs.2016.02.016. Epub 2016 Feb 27. Pharmacol Res. 2016. PMID: 26930420
Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF, Mantuano P, Cozzoli A, Sanarica F, Massari AM, Conte E, Fonzino A, Giustino A, Rolland JF, Quaranta A, De Bellis M, Camerino GM, Grange RW, De Luca A. Capogrosso RF, et al. Among authors: mantuano p. J Appl Physiol (1985). 2017 Apr 1;122(4):828-843. doi: 10.1152/japplphysiol.00776.2015. Epub 2017 Jan 5. J Appl Physiol (1985). 2017. PMID: 28057817 Free article.
Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds.
Gamberi T, Fiaschi T, Valocchia E, Modesti A, Mantuano P, Rolland JF, Sanarica F, De Luca A, Magherini F. Gamberi T, et al. Among authors: mantuano p. J Proteomics. 2018 Jan 6;170:43-58. doi: 10.1016/j.jprot.2017.09.009. Epub 2017 Sep 28. J Proteomics. 2018. PMID: 28966053
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.
Capogrosso RF, Mantuano P, Uaesoontrachoon K, Cozzoli A, Giustino A, Dow T, Srinivassane S, Filipovic M, Bell C, Vandermeulen J, Massari AM, De Bellis M, Conte E, Pierno S, Camerino GM, Liantonio A, Nagaraju K, De Luca A. Capogrosso RF, et al. Among authors: mantuano p. FASEB J. 2018 Feb;32(2):1025-1043. doi: 10.1096/fj.201700182RRR. Epub 2018 Jan 3. FASEB J. 2018. PMID: 29097503 Free PMC article.
Therefore, these data suggest that S48168/ARM210 may be a safe therapeutic option, at the dose levels tested, for the treatment of Duchenne muscular dystrophy (DMD).-Capogrosso, R. F., Mantuano, P., Uaesoontrachoon, K., Cozzoli, A., Giustino, A., Dow, T., Srinivassa …
Therefore, these data suggest that S48168/ARM210 may be a safe therapeutic option, at the dose levels tested, for the treatment of Duchenne …
Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy.
Mantuano P, Sanarica F, Conte E, Morgese MG, Capogrosso RF, Cozzoli A, Fonzino A, Quaranta A, Rolland JF, De Bellis M, Camerino GM, Trabace L, De Luca A. Mantuano P, et al. Biochem Pharmacol. 2018 Aug;154:89-103. doi: 10.1016/j.bcp.2018.04.022. Epub 2018 Apr 21. Biochem Pharmacol. 2018. PMID: 29684379
28 results